drugset / Trial / NCT01568580
Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to study the evaluation of efficacy and safety of GreenGene (Recombinant Factor VIII).
Timeline
- Start
- 2004-12
- Primary completion
- 2006-09
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GreenGene | Protein / enzyme biologic | 10 iu/kg | Intravenous |
| Subject | GreenGene | Protein / enzyme biologic | 50 iu/kg | Intravenous |